Make every bite count.
Across UT MD Anderson, teams collaborated to expand access, comfort and connection in ways that improved the experience for every patient we serve.
The Cancerwise podcast features insights from UT MD Anderson experts on cancer diagnosis and treatment, research breakthroughs, and prevention, as well as stories from survivors and caregivers who’ve faced cancer firsthand.
MD Anderson data scientist Iakovos Toumazis will further IDSO's goal to bring data science to inform decision-making for cancer control and public health
National tour with MD Anderson as presenting sponsor
New members bring expertise in immune therapy resistance, cancer vaccines, bioengineering, tumor evolution and drug development
Leveraging lessons from cancer immunotherapy to develop better treatments for autoimmunity
The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
Our teams were recognized based on several criteria, including creating a culture of delivering high-quality, safe care and providing exceptional experience for patients, employees and the community. The awards reflect staff, providers, trainees and volunteers, and their commitment to quality cancer care.
The University of Texas MD Anderson Cancer Center today was awarded over $29 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of impactful prevention programs, groundbreaking cancer research efforts and faculty recruitment.
